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Abstract: Persistent polyclonal B-cell lymphocytosis (PPBL) is a rare and recently described 
entity. The review of the literature show PPBL is diagnosed predominantly but not exclusively in 
women, usually smokers. PPBL is recognized by a moderate, chronic and absolute lymphocytosis 
(4 × 109/l) in the peripheral blood. In 10% of cases without lymphocytosis, the PPBL diagnosis 
has to be suggested by peripheral blood examination showing in all cases atypical binucleated 
lymphocytes. A polyclonal serum IgM is also associated and HLA-DR7 expression is present 
in most cases. Contrary to B-cell chronic lymphoproliferative disorders (B-CLPD), peripheral 
B cells are polyclonal with kappa and lambda light-chain expression and no clonal rearrange-
ment of immunoglobulin heavy chain genes is usually demonstrated. The detection of an extra 
isochromosome for the long arm of chromosome 3 +i(3)(q10) has to be considered as a speciﬁ  c 
marker of PPBL. We performed conventional cytogenetic analysis (CCA) in 111 patients with 
typical PPBL we followed-up more than 4 years. +i(3q) was detected in 34% (33/98), PCC in 
8% (8/98) and both abnormalities in 31% (30/98). CCA showed neither +i(3q) nor PCC in 28% 
(27/98). Fluorescence in situ hybridization (FISH) was also performed in 84 cases and +i(3q) was 
detected in 71% (60/84). When combining both procedures in 84 patients, +i(3q) was detected 
in 17 patients with negative CCA and was conﬁ  rmed in 43 patients with positive CCA. CCA 
and FISH were both negative in 24 cases. Whether patients with PPBL are at increased risk of 
hematological malignancy remains unclear. After a median follow-up of 4.4 years, most PPBL 
patients presented a stable clinical and biological course. Six patients died from pulmonary 
cancer, myocardial infarction, cerebral aneurysm rupture or diffuse large B-cell lymphoma. Two 
patients had IgM monoclonal gammopathy of undetermined signiﬁ  cance (MGUS) at the time 
of PPBL diagnosis and two other patients developed IgM MGUS respectively 12 and 22 years 
after PPBL diagnosis. A malignant non Hodgkin's lymphoma (NHL) appeared in 3 additional 
patients: two patients presented diffuse large B cell lymphoma and 1 patient a splenic marginal 
zone lymphoma. In conclusion, the possibility of PPBL to evolve toward a clonal proliferation, 
malignant lymphoma or secondary solid cancer lead us to consider PPBL not as a benign pathol-
ogy. We recommend a careful and continued clinical and biological long-term follow-up in 
all PPBL patients.
Keywords: polyclonal lymphocytosis, binucleated lymphocytes, +i(3q), premature chromosome 
condensation
Introduction
Benign or reactive lymphocytosis with an absolute lymphocyte count 4 × 109/l is 
common in children and young adults and is usually related to infectious mononucleosis 
or other viral infections. In contrast, benign lymphocytosis in adults is unusual: 
transient absolute lymphocytosis has been described in “stress”-related emergency 
trauma and medical conditions but it lasts for only a few hours (Thomassen et al 1986). 
Persistent lymphocytosis is usually related to chronic lymphoproliferative disorders 
(CLPD), most commonly of B-cell origin (B-CLPD). A lymphocytosis in this age 
group indicates B-chronic lymphocytic leukemia (B-CLL), B-chronic prolymphocytic 
leukemia (B-PLL), hairy cell leukemia (HCL), Waldenström’s macroglobulinemia, OncoTargets and Therapy 2008:1 60
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follicular lymphoma with leukemic phase, splenic lymphoma 
with villous lymphocytes (SLVL), or intermediate lym-
phoma. These disorders are characterised by a chronic 
course, typical morphologic appearance of lymphocytes on 
peripheral blood smears, exclusively either kappa or lambda 
light-chain expression on B-cells surface, caryotypic abnor-
malities, and expansion of a clone of neoplastic lymphocytes. 
Conversely, polyclonal lymphocytosis can be observed 
in hyposplenic states (Wilkinson et al 1983), in nodular 
lymphocyte predominant Hodgkin’s disease (Mariette et al 
1993), in rheumatoid polyarthritis (Plater-Zirberck et al 
1985) and in other medical conditions such as Gaucher 
disease (Marty et al 1988).
Gordon and colleagues (1982) described a syndrome 
associating chronic absolute lymphocytosis, polyclonal B-cell 
lymphocytosis with binucleated lymphocytes (PPBL) in the 
peripheral blood and a polyclonal increase of serum IgM in 
three women, all of whom expressed the HLA-DR7 antigen. 
We subsequently described cytogenetic abnormalities in 
seven patients with PPBL, including an additional isochro-
mosome for the long arm of chromosome 3 +i(3q) in 6 cases 
and premature chromosome condensation (PCC) in all 
7 cases (Troussard et al 1994). That cytogenetic proﬁ  le was 
subsequently conﬁ  rmed in a large number of case reports.
The real incidence of PPBL has never been calculated 
because PPBL is probably underdiagnosed, as most patients 
are asymptomatic. Nevertheless PPBL appears to be a rare 
haematological disorder and underreported (Delannoy 
et al 1993; Agrawal et al 1994; Mossafa et al 1999). In this 
review, we focus our interest on the clinical, morphologic, 
immunologic and karyotypic ﬁ  ndings in patients with PPBL. 
We had the opportunity to collect the clinical data and the 
specimens of a very large cohort of 111 patients with typical 
PPBL in France. We will present the speciﬁ  c clinical and 
biological data in that very large cohort and also discuss the 
aetiology of PPBL.
The identiﬁ  cation of PPBL is important to distinguish 
PPBL from others B-CLPD. Whether this syndrome represents 
a premalignant (Casassus et al 1987) or benign disease remains 
unclear. Although long-term follow-up suggests that whenever 
malignant progression occurs, it is after a long latency. The 
benign clinical course and lack of biological evolution in the 
majority of PPBL cases suggest that the recognition is so 
important that aggressive therapy could be avoided.
Clinical data
PPBL affects mainly adults but it was reported in a 3-month-old 
baby (Gomez et al 2000). The median age is approximately 
40–50 years. Most patients are asymptomatic: the presence 
of splenomegaly is observed in 10% of cases and only a 
very few patients had hepatomegaly or adenopathy based on 
clinical examination and/or thoracic and abdominal comput-
erised tomography. Antiphospholipid/cofactor antibodies of 
immunoglobulin (IgM) isotype or lupus anticoagulant was 
also reported in a few cases (Granel et al 2002).
The majority of PPBL patients present with an absolute 
and moderate lymphocytosis 4 × 109/L. In 10% of patients 
without absolute lymphocytosis, PPBL diagnosis has to 
be suggested by cytology and conﬁ  rmed by detection of 
typical binucleated lymphoid cells and +i(3q). Neutrophil 
and platelet counts are usually normal. Analysis of serum 
immunoglobulin reveal persistent, stable and polyclonal 
increase of IgM levels, with low to normal levels of IgA 
and IgG. No increase incidence of infection or any clini-
cal evidence of defective humoral immunity was notiﬁ  ed. 
Ninety percent of PPBL patients are HLA-DR7-positive 
(Troussard et al 1996) but no patient complained adult 
coeliac disease.
Cytology: presence of binucleated 
lymphocytes in the peripheral blood
Binucleated lymphocytes are detected in the peripheral 
blood of all PPBL patients. The majority of lymphocytes 
are large with abundant faintly, basophilic cytoplasm and in 
all patients a characteristic nuclei demonstrating a rounded 
or more commonly irregular form with variable numbers 
of binucleated cells (Figure 1). Nuclei range from those 
demonstrating a slight indentation to bilobed forms with 
the inconstant presence of an internuclear linkage in a 
few cells. Nuclear chromatin is dense and nucleoli usually 
visible. Binucleated lymphocytes are not speciﬁ  c of PPBL 
and have been described after irradiation (Roy-Taranger 
et al 1965) and more rarely in B-CLPD, as HCL Japanese 
variant (Troussard et al 1997), B-CLL or marginal zone 
B-cell lymphoma (Samson et al 2002).
The investigation of bone marrow biopsies is limited in 
PPBL. The bone marrow is inﬁ  ltrated by a slight or moderate 
intravascular and at a lesser extent interstitial lymphocytic 
pattern (Feugier et al 2004).
Immunophenotyping: a polyclonal 
expansion of memory B-cells
The lymphocytosis is clearly of the B-cell type. Lymphocytes 
react with the CD19, CD20 and CD22 antigens. Both kappa 
and lambda light-chain are expressed, indicating a polyclonal 
expansion of the B-lymphocyte pool (Troussard et al 1994; OncoTargets and Therapy 2008:1 61
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Mossafa et al 1996). Double labeling performed on cytocentrifuge 
slides with kappa and lambda monoclonal antibodies by immu-
noenzymatic methods using ABC (avidin biotin peroxydase 
complex) and APAAP (alkaline phosphatase antialkaline 
phosphatase) procedures showed both kappa and lambda light-
chain in binucleated lymphocytes and nonbinucleated lymphoid 
cells (Troussard et al 1994). When using cytoﬂ  uorometry, the 
cellular DNA content determination and proliferation index 
analysis is not different from that of the controls and diploidy 
can be demonstrated in binucleated lymphocytes by image 
analysis and manual cell sorting.
Peripheral B cells co-express IgM and IgD, suggesting 
that they derive from a naive B-cell subset (Himmelmann 
et al 2001; Loembé et al 2002). CD27 is a type I glycoprotein 
expressed on some B cells and the majority of T cells, and is 
a member of the tumor necrosis factor (TNF) receptor family, 
with unique cysteine-rich motifs. CD27+ B cells exhibit several 
features of primed (memory) B cells. In ﬁ  ve PPBL patients, a 
large increase in the number of IgD+, CD27+ double positive B 
cells, (60%–88% versus 8%–15% in the controls) was detected 
in the peripheral blood. The number of CD27+ which also 
coexpress receptor-type protein tyrosine phosphatase CD148 
(CD27+ CD148+ double-positive B cells) was also increased 
(Himmelmann et al 2001). PPBL B cells express CD25 and 
CD23 with usually no or low CD5 antigens (Salcedo et al 2002). 
An unusual CD5 positive phenotype can be observed (Reeder 
et al 1999). The cells also express CD24, CD79, FMC7, and 
CD21 at levels higher than normal B lymphocytes. Taken 
together, all those data suggest B-cell population is a memory 
B-cell population distinguished by the expression of CD27, 
IgMhigh, CD21high, CD5low, and CD23low, a proﬁ  le associated with 
a normal marginal B-cell compartment (Salcedo et al 2002).
An associated abnormality of T cells has not been found: not 
only was the absolute number of T-cells normal but the CD4 
and CD8 cells subsets were quantitatively normal as well.
Chromosome analysis in PPBL 
patients: an unique cytogenetic 
proﬁ  le associating i(3q) 
and premature chromosome 
condensation
Following stimulation of peripheral blood lymphocytes with 
pokeweed, the presence of an extra chromosome 3 long arm 
i(3q) was identiﬁ  ed for the ﬁ  rst time in 1989. +i(3)(q10) 
was present in 3/26 metaphases in only 1/6 patients with 
Figure 1 Morphologic features showing typical binucleated cells in a PPBL patient.OncoTargets and Therapy 2008:1 62
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PPBL (Perreault et al 1989). However, when using the 
combinations of the tetrad-canoyl-o-phorbol 13 acetate 
(TPA) and lipopolysaccharide (LPS) from Escherichia 
coli used in some samples, which encourages B lymphoid 
proliferation, +i(3q) (Figure 2) was detected more frequently 
and was observed in 6/7 PPBL patients (Mossafa et al 
1996). +i(3q) is distributed and restricted in nonbinucleated 
B cells whatever the light chain expression (Troussard et al 
1999). In B-CLPD, distinct, recurring and highly consistent 
chromosomal changes are observed: however +i(3q)(q10) 
is rarely identiﬁ  ed and to our knowledge was detected in 
only one case of Waldenstrom macroglobulinemia (Wong 
et al 2002) and in a few cases of chronic lymphocytic leuke-
mia (Specchia et al 2002; Wong et al 2002). G1 premature 
chromosome condensation (PCC) (Figure 3) is also a char-
acteristic of PPBL patients. PCC, originally described in 
virally infected cells, is also detected in normal cells treated 
with mould extract, cytochalasin B. The common feature is 
the presence of asynchronous mitosis in multinucleated cells. 
One nucleus must be in metaphase and its presence results in 
the condensation of the chromatin of an adjacent interphase 
nucleus. The morphology depends on the interphase cells. In 
PPBL, the morphology of the PCC indicate condensation of 
G1 and G2 cells, exhibiting single and double chromatids, 
respectively. PCC of S-phase cells is not observed in any 
case. Interestingly PCC can be associated with +i(3q). As 
both abnormalities, either +i(3q) or PCC, are rarely present in 
other benign or malignant proliferations, a strong correlation 
between PPBL and i(3q) and/or PCC is probable.
In a large series of 111 patients with PPBL we follow-up, 
conventional cytogenetic analysis (CCA) allowed us to 
identify extra isochromosome +i(3)(q10) in 34% (33/98), 
PCC in 8% (8/98) and both abnormalities in 31% (30/98). 
CCA showed neither +i(3)(q10) nor PCC in 28% (27/98). 
Isochromosome +i(3q) was also studied in interphase with 
alpha-satellite chromosome 3 speciﬁ  c (SO CEP3) and LSI 
3’BCL6 (3q27) break apart probes obtained from Abott 
Molecular (Rungis, France) and was detected in 71% (60/84). 
We also combined CCA and FISH analysis in 84 patients: 
after FISH, +i(3q) was detected in 17 patients with negative 
CCA and was conﬁ  rmed in 43 patients with positive CCA. 
CCA and FISH were both negative in 24 cases.
Trisomy 3 can be detected in addition to extra +i(3)(q10), 
suggesting that PPBL is associated with an increase 
frequency of chromosome 3 instability (Callet-Bauchu et al 
1999). When excluding +i(3)(q10) and PCC, chromosomal 
instability is also a common occurrence in PPBL and is 
observed in more than two thirds of PPBL patients. It 
is characterised by the presence of others independent 
clonal abnormalities, del(6q), +der(8) or +8, poliploid 
karyotype, structural changes, aneuploidy and/or non clonal 
chromosomal aberrations with either loss or more frequently 
gain of chromosomes (Mossafa et al 2004).
The long-term follow-up of PPBL remains to be 
determined and the role of i(3q) in the pathogenesis of PPBL 
is debatable. The gain of chromosome 3q was demonstrated 
as a pivotal genetic aberration transition from severe 
dysplasia/carcinoma in situ to invasive cervical carcinoma 
of the uterine cervix (Heselmeyer et al 1996). It could have 
a role in the possibility of emergence of a clonal and/or 
malignant subpopulation. On the other hand, isochromosome, 
i(3)(q10) inhibits muscle differentiation, when transferred 
into myoblasts. The i(3q) is in that model able to induce 
an abnormal phenotype of the cells including abnormal 
centrosome ampliﬁ  cation, aneuploidy and loss of G1 arrest 
following γ-irradiation (Smith et al 1998).
Molecular studies
To determine if the lymphocytosis observed in PPBL 
patients represented a clonal, biclonal, polyclonal or random 
expansion of cells, immunoglobulin gene rearrangements 
were examined. In almost all cases, molecular studies 
show a polyclonal pattern. Southern hybridization of DNA 
with immunoglobulin probes was performed in 14 patients 
and failed to show any clonal population in 12 patients; 
however two patients curiously showed an immunoglobulin 
gene rearrangement (Chan et al 1990; Delage et al 1992). 
Polymerase chain reaction (PCR) procedures using either 
consensus primers for the FR3 portion of the variable region 
and/or VH family speciﬁ  c primers for the FR1 region (12,16) 
show also a polyclonal expansion of B cells.
The study of Ig-V gene somatic mutations was rarely 
performed in the B cells isolated from PPBL patients 
3 3 i[3q]
Figure 2 Partial karyotype showing +i(3q) -R-banding from patient with persistent 
polyclonal B-cell lymphocytosis.OncoTargets and Therapy 2008:1 63
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breakpoint region (MBR) and the minor cluster region (mcr). 
When using a quantitative real-time PCR, Himmelmann and 
colleagues (2001) demonstrated the presence in the peripheral 
blood of a high number of 1055–3487 t(14; 18)-positive cells 
per 106 B cells, as compared to only nine positive cells in 
106 B cells obtained from a buffy coat from a healthy donor. 
BCL-2/IgH rearrangements were also identiﬁ  ed in nearly 50% 
of normal individuals: the frequency of translocations increases 
with age and heavy smoking. In those cases, the frequency of 
the BCL-2/IgH rearrangements is estimated to be equal or less 
than one in 105 to 106 B cells. Despite the presence of BCL-2/
IgH rearrangements, the accumulation of B lymphocytes in 
PPBL is probably not related to an overexpression of BCL-2 
protein (Himmelmann et al 2001; Lancry et al 2001).
Functional defect in PPBL: 
conﬂ  icting signals from the CD40 
survival and Fas death pathways
The accumulation of polyclonal binucleated mature B 
lymphocytes in the peripheral blood could be explained 
by defects in apoptosis and/or uncontrolled cell growth. 
(Loembé et al 2002; Salcedo et al 2002). However, the relevant 
marker of memory B cells thus far identiﬁ  ed is the presence 
of somatically mutated high-afﬁ  nity antigen receptors. When 
combining both studies, 90 clones were analysed from 6 PPBL 
patients and 85.5% clones (77/90) were mutated, a proportion of 
sequences higher than that reported for normal blood lympho-
cytes. Mutations in PPBL cells are present in all three framework 
regions (FR) as well as CDR1 and CDR2 but the number of 
observed R mutations is usually lower than that expected for FR 
but higher than expected for CDR, suggesting no evidence of 
positive antigenic selection following somatic hypermutation.
Using nested PCR assay, BCL-2/IgH rearrangements are 
identiﬁ  ed in PPBL patients (Delage et al 1997, 1998, 2001; 
Granados et al 1998). We also studied the presence of BCL-2/
IgH rearrangements in a series of eight PPBL patients and dem-
onstrated the constant presence of BCL-2/IgH rearrangements 
in 8/8 DNA samples, multiple rearrangements in 3/8 cases 
and also normal BCL-2 protein expression, as compared 
to BCL-2 level in B lymphocytes from healthy population 
(Lancry et al 2001). When pooling all the published results, 
BCL-2/IgH rearrangements are detected both in the major 
PCC
Figure 3 Premature chromosome condensation (PCC) R-banding of an early G1-PCC with condensed single chromatide.OncoTargets and Therapy 2008:1 64
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Overexpression of the antiapoptotic protein Bcl-2 in CLL 
is associated with an aggressive clinical course, chemo-
therapy resistance and shortened survival. In PPBL, Bcl-2 
is equivalent to that detected in lymphocytes of healthy 
individuals (Lancry et al 2001). The polyclonal B-cells are 
resistant to Fas stimulation despite a high expression of Fas 
receptor and apoptosis is induced after etoposide treatment 
(Roussel et al 2003). In contrast to normal B cells, defects 
of the CD40 survival pathway has been described in PPBL 
patients (Loembé et al 2001). B-cell accumulation observed 
in PPBL could result from conﬂ  icting signals from the CD40 
survival and Fas death pathways.
PPBL requires a careful a long-term 
follow-up
Whether patients with PPBL are at increased risk of 
hematologic malignancy remains unclear (Troussard et al 
1999). One patient developed a malignant pulmonary 
blastoma 20 years after PPBL was diagnosed (Lawlor et al 
1991). One additional PPBL patient developed B large cell 
lymphoma 19 years after PPBL diagnosis (Roy et al 1998). 
After a median follow-up of 4.4 years (0.5–29 years), PPBL 
patients presented a stable clinical and biological course in 
99/111 cases (89%). In two patients, we noticed a decrease 
of lymphocytosis and the number of binucleated lymphocytes 
but isochromosome +i(3q) persisted 2 years after stopping 
tobacco. Six patients died: one heavy smoker patient from 
pulmonary cancer nine years after PPBL diagnosis, 1 from 
myocardial infarction, 1 from cerebral aneurysm rupture, 
2 deaths from unknown causes and 1 from diffuse large B-cell 
lymphoma described later. Two patients had IgM monoclonal 
gammopathy of undetermined signiﬁ  cance (MGUS) at the 
time of PPBL diagnosis. Two other patients developed IgM 
MGUS (serum IgM, 6.9 g/L and 12.88 g/L) 12 and 22 years 
after PPBL diagnosis, respectively. In those 4 cases, no 
bone marrow biopsy was performed. IgM gammopathy 
remained asymptomatic and stable after a median follow-
up of 102 months (range 52–348). Two patients presented 
pulmonary cancer in the clinical course of PPBL and one 
patient developed cervical cancer 12 years after diagnosis of 
PPBL. A malignant non-Hodgkin’s lymphoma (NHL) was 
also observed in 3 additional patients: two patients presented 
diffuse large B cell lymphoma (DLBCL) and 1 patient a 
splenic marginal zone lymphoma (SMZL). It therefore 
appears that, while the majority of patients demonstrate a 
polyclonal B lymphocytosis based on immunological and 
genotypic analysis, the emergence of a clonal sub-population 
is possible (Cornet et al 2008).
Etiology of PPBL
The aetiology of polyclonal B-cell lymphocytosis remains 
elusive. An association with cigarette smoking was suggested 
by Carstairs and colleagues (1985). These authors described 
four patients with PPBL, all cigarette smokers, in one of 
whom the lymphocyte count and morphology were abnormal 
when she smoked and not when she abstained. However, the 
role and inﬂ  uence of environmental factors and particularly 
tobacco is debatable, as we observed one female patient who 
had never smoke and we were unable to detect binucleated 
lymphocytes on cytocentrifuge slides in 30 asymptomatic 
female heavy smokers. Lymphocyte binuclearity is not 
observed in normal individuals and has been described only 
after low-dose irradiation (Roy-Taranger et al 1965).
The binucleated morphology of lymphocytes could 
suggest an association with persistent viral infection such 
as Epstein-Barr virus (EBV) (Mittereer et al 1995). EBV 
is responsible for a polyclonal lymphoproliferative process 
in patients with immune deﬁ  ciency. Chow and colleagues 
(1992) demonstrated the presence of EBV in the peripheral 
blood lymphocytes (but not in binucleated lymphocytes) 
from one patient by in situ hybridization and PCR. These 
studies are insufﬁ  cient to exclude and/or conﬁ  rm the role of 
EBV in PPBL.
The association with HLA-DR-7 phenotype suggests a 
possible genetic disorder. Taken together with the presence 
of chararacteristic, binucleated lymphocytes in asymptomatic 
family members, we suggest a genetic predisposition as a 
more likely possibility. The description of PPBL in identical 
twins (Carr et al 1997) and also in a family including PPBL 
in a brother and sister (Himmelmann et al 2001) strengthens 
that hypothesis as well as the detection of multiple BCL-2/
IgH rearrangements in 8/10 individuals among ﬁ  rst-degree 
relatives (Delage et al 2001).
Conclusion
PPBL is characterised by persistent and stable lymphocytosis 
(in but not exclusively female patients) with binucleated 
lymphocytes on peripheral blood smears and a polyclonal 
increase of serum IgM. Immunophenotyping revealed in all 
cases a polyclonal expansion of B-lymphocytes. Whether 
this syndrome represents a premalignant disease process or 
an actual polyclonal lymphocytosis remains unsettled. The 
occasional reports of clonal Ig rearrangements in this disorder 
suggest that in a minority of cases the polyclonal expansion 
may be followed by the emergence of one predominant clone. 
The demonstration of clinically, benign, clonal lymphoid 
population is well recognized in several T cell disorders such OncoTargets and Therapy 2008:1 65
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as large granular lymphocytes expansion. The benign clinical 
course and the lack of biological evolution in the majority 
of cases suggest that the importance in recognition of this 
disorder lies in the avoidance of aggressive therapy for these 
cases. A careful follow-up of these patients is mandatory: 
prospective immunological and genetic studies performed at 
different stages of the disease may clarify this issue.
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